CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
CapsoVision, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.67+0.14 (+2.14%)
Close on Oct 19, 2026
- Market cap
- $333.08M
- P/E (TTM)
- –
- Dividend yield
- –
CapsoVision statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | CapsoVision | Industry median |
|---|---|---|
| Market Cap | $333.81M | $229.23M |
| Enterprise Value | $333.81M | $194.73M |
| PS Ratio | 24.03 | 3.14 |
| PB Ratio | 25.35 | 3.19 |
| P/TBV Ratio | 25.35 | 4.69 |
Enterprise value
| Measure | CapsoVision | Industry median |
|---|---|---|
| EV / Sales | 24.03 | 2.93 |
Income (trailing twelve months)
| Measure | CapsoVision | Industry median |
|---|---|---|
| Revenue | $13.89M | $102.39M |
| Gross Profit | $7.07M | $60.36M |
| Operating Income | -$30.16M | -$4.31M |
| Pretax Income | -$29.81M | -$2.26M |
| Net Income | -$29.83M | -$6.57M |
| EBITDA | -$29.93M | -$1.98M |
Margins
| Measure | CapsoVision | Industry median |
|---|---|---|
| Gross Margin | 50.9% | 55.1% |
| Operating Margin | -217.1% | -6.04% |
| Pretax Margin | -214.6% | -4.11% |
| Profit Margin | -214.7% | -10.5% |
| EBITDA Margin | -215.5% | -2.67% |
| FCF Margin | -200.8% | -0.30% |
Returns
| Measure | CapsoVision | Industry median |
|---|---|---|
| Return on Assets (ROA) | -212.2% | -13.3% |
| Return on Capital Employed (ROCE) | -224.9% | -9.07% |
Growth
| Measure | CapsoVision | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 11.0% | 8.85% |
Balance sheet
| Measure | CapsoVision | Industry median |
|---|---|---|
| Equity (Book Value) | $13.17M | $57.36M |
| Book Value Per Share | $0.26 | $2.81 |
| Tangible Book Value | $13.17M | $10.71M |
| Working Capital | $12.12M | $54.64M |
Financial position
| Measure | CapsoVision | Industry median |
|---|---|---|
| Current Ratio | 3.35 | 2.50 |
| Quick Ratio | 0.44 | 1.54 |
Cash flow (trailing twelve months)
| Measure | CapsoVision | Industry median |
|---|---|---|
| Operating Cash Flow | -$27.82M | -$653.46K |
| Capital Expenditures | -$68.00K | -$3.69M |
| Free Cash Flow | -$27.89M | -$835.02K |
| FCF Per Share | -$0.56 | -$0.02 |
Efficiency
| Measure | CapsoVision | Industry median |
|---|---|---|
| Asset Turnover | 0.99 | 0.59 |
| Inventory Turnover | 1.76 | 2.21 |
| Revenue Per Employee | $140.31K | $322.75K |
| Profits Per Employee | -$301.30K | -$52.11K |
| Employee Count | 99 | 197 |
Dividends and yields
| Measure | CapsoVision | Industry median |
|---|---|---|
| Earnings Yield | -8.94% | -6.92% |
| FCF Yield | -8.35% | -0.62% |
Shares
| Measure | CapsoVision | Industry median |
|---|---|---|
| Shares Outstanding | 50,046,900 | 44,856,700 |
| Shares Change (YoY) | 2110.7% | 3.35% |
| Shares Change (QoQ) | 0.39% | 0.27% |
| Float | 37,462,700 | 36,934,400 |
| Shares Held by Insiders | 25.1% | 10.6% |
| Shares Held by Institutions | 10.2% | 63.5% |
Taxes
| Measure | CapsoVision | Industry median |
|---|---|---|
| Income Tax | $24.00K | $1.52M |
Scores
| Measure | CapsoVision | Industry median |
|---|---|---|
| Altman Z-Score | 20.41 | 1.95 |
| Piotroski F-Score | 3 | 5 |
| Beneish M-Score | -3.48 | -2.64 |
Calculated by StockData from CapsoVision's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.